• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.

作者信息

Paulsen T, Aas T, Børresen A L, Varhaug J E, Lønning P E, Akslen L A

出版信息

Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a.

DOI:10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a
PMID:9036883
Abstract
摘要

相似文献

1
Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer.血管生成不能预测局部晚期乳腺癌患者对阿霉素单一疗法的临床反应。
Int J Cancer. 1997 Feb 20;74(1):138-40. doi: 10.1002/(sici)1097-0215(19970220)74:1<138::aid-ijc23>3.0.co;2-a.
2
Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.TP53基因改变和c-erbB-2表达对局部晚期乳腺癌多柔比星治疗反应的影响。
Cancer Res. 2001 Mar 15;61(6):2505-12.
3
[Evaluation of the angiogenic process in breast carcinoma--correlations with cancer aggressiveness].[乳腺癌血管生成过程的评估——与癌症侵袭性的相关性]
Rev Med Chir Soc Med Nat Iasi. 2004 Jul-Sep;108(3):657-61.
4
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?HER2过表达能否预测转移性乳腺癌患者对聚乙二醇化脂质体阿霉素的反应？
Ann Oncol. 2005 Mar;16(3):516-7. doi: 10.1093/annonc/mdi078. Epub 2005 Jan 10.
5
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.特定的P53突变与乳腺癌患者对阿霉素的原发耐药性相关。
Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811.
6
Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.拓扑异构酶IIα及其他预后因素对晚期乳腺癌表柔比星化疗的预测价值
Br J Cancer. 1998 Jun;77(12):2267-73. doi: 10.1038/bjc.1998.377.
7
Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.乳腺癌中的血管生成标志物——用于确定抗血管生成药物优先级的潜在有用工具。
Asian Pac J Cancer Prev. 2013;14(12):7651-6. doi: 10.7314/apjcp.2013.14.12.7651.
8
Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome.乳腺癌的诱导化疗：预测标志物及其与预后的关系。
Int J Oncol. 2003 Jun;22(6):1319-25.
9
Prognostic significance of p53, angiogenesis, and other conventional features in operable breast cancer: subanalysis in node-positive and node-negative patients.p53、血管生成及其他传统特征在可手术乳腺癌中的预后意义：对淋巴结阳性和阴性患者的亚组分析
Int J Oncol. 1998 May;12(5):1117-25. doi: 10.3892/ijo.12.5.1117.
10
Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.局部晚期乳腺癌女性患者采用每周一次阿霉素单药进行初始全身治疗：临床经验及预测预后的参数
Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960.

引用本文的文献

1
Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.肾小球样微血管增生与乳腺癌对化疗无反应有关。
Br J Cancer. 2011 Jun 28;105(1):9-12. doi: 10.1038/bjc.2011.203. Epub 2011 Jun 14.
2
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients.
Br J Cancer. 2002 Jun 17;86(12):1905-8. doi: 10.1038/sj.bjc.6600325.
3
Independent prognostic importance of microvessel density in endometrial carcinoma.微血管密度在子宫内膜癌中的独立预后意义。
Br J Cancer. 1998 Apr;77(7):1140-4. doi: 10.1038/bjc.1998.189.